Last10K.com

Pacific Biosciences Of California, Inc. (PACB) SEC Filing 8-K Material Event for the period ending Saturday, May 14, 2022

Pacific Biosciences Of California, Inc.

CIK: 1299130 Ticker: PACB

View differences made from one to another to evaluate Pacific Biosciences Of California, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pacific Biosciences Of California, Inc..

Continue

Assess how Pacific Biosciences Of California, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pacific Biosciences Of California, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: PACB
CIK: 1299130
Form Type: 8-K Corporate News
Accession Number: 0001104659-22-061927
Submitted to the SEC: Tue May 17 2022 4:01:23 PM EST
Accepted by the SEC: Tue May 17 2022
Period: Saturday, May 14, 2022
Industry: Laboratory Analytical Instruments
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/pacb/0001104659-22-061927.htm